Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
MYC is one of the most deregulated oncogenes on multiple levels in cancer. As a node transcription factor, MYC plays a diverse regulatory role in many cellular processes, including cell cycle and metabolism, both in physiological and pathological conditions. The relentless growth and proliferation o...
Main Authors: | Laura Vízkeleti, Sándor Spisák |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/13/1745 |
Similar Items
-
Alteraciones del gen c-Myc en la oncogénesis = c-Myc gene alterations in oncogenesis
by: Ospina Pérez, Mariano, et al.
Published: (2011-12-01) -
Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression
by: Viviana Anelli, et al.
Published: (2017-03-01) -
Oncogenes asociados al cáncer oral
by: Gabriela Liseth Vaca-Altamirano, et al.
Published: (2023-11-01) -
The political economy of privatization and deregulation /
by: Bailey, Elizabeth E., et al.
Published: (1995) -
Immune evasion: An imperative and consequence of MYC deregulation
by: Bastian Krenz, et al.
Published: (2024-10-01)